|

Heart Disease Clinical Trials in Arkansas

53 recruiting studies across 5 cities

All Trials in Arkansas

Phase
Trial Phase Location
Physical Activity and Community EmPOWERment ProjectN/AFayetteville
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Hot Springs
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava IsolationN/AJonesboro
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial FibrillationN/AJonesboro
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsN/AJonesboro
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF StudyN/AJonesboro
BoxX-NoAF Clinical TrialN/AJonesboro
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationN/AJonesboro
Detection of Atrial Fibrillation Using PPG From Smartphone Cameras—Jonesboro
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Jonesboro
Elite AF IDE Trial (Elite AF)N/AJonesboro
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial FibrillationN/AJonesboro
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation—Jonesboro
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Jonesboro
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System—Jonesboro
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyN/AJonesboro
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Jonesboro
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Jonesboro
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/AJonesboro
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AFN/AJonesboro
The Fourth Left Atrial Appendage Occlusion StudyN/AJonesboro
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)—Jonesboro
Tracking Results of Ablations to Combat AF Registry Generation 2—Jonesboro
ViewFlex X ICE First-in-Human Study—Jonesboro
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Little Rock
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Little Rock
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)Phase 2Little Rock
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPhase 2Little Rock
Abbott Vascular Medical Device Registry—Little Rock
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Little Rock
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Little Rock
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve DysfunctionN/ALittle Rock
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)N/ALittle Rock
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Little Rock
Encore PFO Closure Device - The PerFOrm TrialN/ALittle Rock
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3Little Rock
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Little Rock
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/ALittle Rock
Left vs Left Randomized Clinical TrialN/ALittle Rock
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Little Rock
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Little Rock
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Little Rock
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmN/ALittle Rock
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsN/ALittle Rock
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Little Rock
Prevail Global StudyN/ALittle Rock
Product Surveillance Registry—Little Rock
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention—Little Rock
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial FibrillationPhase 3Little Rock
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitablePhase 3Little Rock
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Little Rock
The HEARTFELT StudyN/ALittle Rock
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/ALittle Rock

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.